Body mass index (BMI) influence on Cetuximab-induced antibody-dependent cellular cytotoxicity in advanced colon cancer

To date, we do not know if the excess of the body mass index (BMI) improves or worsens the outcomes in colorectal cancer treatment, and the correlation between BMI and prognosis remains unclear. A recent study in vitro showed a significant negative correlation between BMI and Cetuximab-induced antib...

Descripción completa

Detalles Bibliográficos
Autores principales: Tralongo, Antonino Carmelo, Caspani, Francesca, Proserpio, Ilaria, Volpi, Lisa, Campiotti, Leonardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Ce-Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883300/
https://www.ncbi.nlm.nih.gov/pubmed/36357605
http://dx.doi.org/10.1007/s11739-022-03124-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883300/
https://www.ncbi.nlm.nih.gov/pubmed/36357605
http://dx.doi.org/10.1007/s11739-022-03124-4

Ejemplares similares